BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15631781)

  • 1. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].
    Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coli.
    Piao WH; Song XG; Liu MC; He Y; Zhang HH; Xu WX; Li ZL; Zhang HQ; Ling SG; Wang GQ
    Protein Expr Purif; 2004 Jun; 35(2):210-7. PubMed ID: 15135395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
    Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
    Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and refolding of a HLA-A*0203-BSP fusion protein and identification of its tetramers].
    Jia QT; Xu LH; Zha QB; Li FY; He XH; Zeng YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):97-101. PubMed ID: 17286897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and characterization of HLA-A * 0201 monomer and tetramer loaded with HCMV antigenic peptide].
    He XH; Xu LH; Liu Y; Cai XC; Zeng YY
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):382-8. PubMed ID: 15971610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes.
    He XH; Xu LH; Liu Y
    World J Gastroenterol; 2005 Jul; 11(27):4180-7. PubMed ID: 16015686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level expression of HLA-A*0203-BSP fusion protein in Escherichia coli and construction of soluble HLA-A*0203 monomer and tetramer loaded with Epstein-Barr virus peptide.
    Jia Q; Xu L; Zha Q; Chi X; Li F; He X
    Cell Mol Immunol; 2007 Aug; 4(4):301-8. PubMed ID: 17764621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In-vitro refolding and biotinylation of soluble HLA-A2-peptide complex].
    Wong XF; Chen H; Wu XW; Liang ZH; Han JY; Huan YF; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):265-8. PubMed ID: 15193213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and identification of HLA-A*1101 tetramer loading with human cytomegalovirus pp65 antigen peptide.
    Li F; Xu L; Zha Q; Chi X; Jia Q; He X
    Cell Mol Immunol; 2007 Apr; 4(2):141-6. PubMed ID: 17484809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers.
    Wu Y; Zhang J; Chen S; Chen A; Wang L; Li J; Zhao T; Zou L; Tang Y; Tingrong L; Wang F
    Immunol Lett; 2004 Apr; 92(3):253-8. PubMed ID: 15081620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.
    Yang J; Jaramillo A; Shi R; Kwok WW; Mohanakumar T
    Hum Immunol; 2004 Jul; 65(7):692-9. PubMed ID: 15301857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
    Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients].
    Deng H; Chong YT; Han XY; Zhang FC; Peng XM; Gao ZL; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):721-4. PubMed ID: 17064461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.